by Raynovich Rod | Jan 7, 2015 | Biopharmaceuticals, Clinical Diagnostics and Tools
Life Science Stocks Up For the Year Biotech stocks resumed their upward move near all time highs in FBT and XBI.We will review many of the stocks in our portfolios at the JPMorgan Conference next week. Motif Summary Rayno Large Cap Biopharma up 36.4% over one year...
by Raynovich Rod | Jan 7, 2015 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
2015: Another Good Year Unless “Something Happens” Life Science stocks had another big year in 2014 up 48% tracking gains for the overall healthcare sector up 35%. Over 10 years the return is 300%! The move up was not a straight line as there were two...
by Raynovich Rod | Jan 5, 2015 | Macro
XLE off 4%, NASDAQ Off 1.57%, Biotech Mainly In The Green After Close: Financials and Materials also hit hard down over 2% Biotech stocks remain a safe harbor in a stormy market freaked out by the energy free-fall. Most major biotech ETFs are up FBT,XBI but the IBB...
by Raynovich Rod | Jan 1, 2015 | 2024 Rayno Biopharmaceuticals Portfolio, 2024 Rayno Tools and Diagnostics Portfolio
Wishing you all a Happy and Prosperous New Year! Biotech stocks were up 47% in 2014. In 2014 the first quarter was the most volatile. Sign up now to receive all of our market and portfolio updates. In December we posted updates on our Rayno Life Science Portfolios:...